RNAZ
USDTransCode Therapeutics Inc. Common Stock
Preço em tempo real
Gráfico de preços
Métricas-chave
Métricas de mercado
Abertura
$9.910
Máximo
$10.450
Mínimo
$9.500
Volume
0.01M
Fundamentos da empresa
Capitalização de mercado
8.7M
Setor
Biotecnologia
País
United States
Estatísticas de negociação
Volume médio
0.14M
Bolsa de valores
NCM
Moeda
USD
Faixa de 52 semanas
Notícias relacionadas
TransCode Therapeutics presents preliminary data from its completed Phase 1a study with TTX-MC138 in metastatic disease at ESMO
TransCode Therapeutics, Inc. (NASDAQ: RNAZ) announces completion of Phase 1a clinical trial with TTX-MC138, an investigational inhibitor of...
TransCode Therapeutics (RNAZ) announces the acquisition of Polynoma and a $25 Million strategic financing by a subsidiary of CK Life Sciences to form a first-in-class unique immuno-oncology and metastatic prevention oncology company
TransCode Therapeutics, Inc. (NASDAQ: RNAZ) ("TransCode or the "Company") announced today that it entered into a definitive agreement to acquire...
Ações relacionadas
BRW
Saba Capital Income & Opportunities Fund SBI
IMCC
IM Cannabis Corp. Common Shares
GCV
Gabelli Convertible and Income Securities Fund Inc. (The)
INTEU
Integral Acquisition Corporation 1 Unit
IBOC
International Bancshares Corporation
Mantenha-se atualizado
Defina um alerta de preço, obtenha atualizações de análise de IA e notícias de mercado em tempo real.